Publication | Closed Access

Pharmacological actions of Y-24180, a new specific antagonist of Platelet Activating Factor (PAF): II. Interactions with PAF and benzodiazepine receptors

ThrombopoiesisMolecular PharmacologyThrombosisBlood PlateletMedicineNew Specific AntagonistPlatelet Activating FactorPharmacotherapyNeurologyPlatelet AntagonistPharmacologyAnticoagulantBenzodiazepine Receptors